Evernorth Specialty Management

Empowering plan sponsors with tools and solutions to make smart, effective benefit decisions in a complex specialty environment.

A doctor has a discussion with their patient

The complex, changing care environment

Changes in the specialty market are creating new paradigms that are causing increased concerns for benefit decision makers, and patient care for your specialty members is tough to consider when affordability stands in your way.

280%

increase in specialty drugs on the market in the past 20 years¹

1. Office of Emerging Therapeutics Reporting as of Jan 2022
2. American Cancer Society Cancer Facts & Figures 2024
3. AAMC, March 2024

expected new cancer patients diagnosed in 2024²

85K

potential physician shortage in the U.S. by 2036³

Competitive specialty drug pricing

Unrivaled specialty drug access

Deep clinical expertise

Care beyond the prescription

Flexible options to manage specialty spend.

Specialty can be a major driver of your total benefit spend. Our specialty services and solutions can help you get the most out of every health care dollar spent on specialty-related treatments, services, and procedures.

-15.8%

specialty trend for payers after adopting our trend management solutions⁴

4. 2023 ESI DTR client sample for plans enrolled for pharmacy benefit coverage with ESI in 2022 and 2023. Potential per member per month (PMPM) savings depends on level of aggressiveness.

$9.53

PMPM savings⁴

More holistic care experiences

An ecosystem of clinical support resources is critical as the health care system faces physician shortages and a growing number of patients.

Accredo, Evernorth's specialty pharmacy, connects the dots between patients, prescribers, case managers and beyond to take care of your specialty members' needs.

In 2023, these programs and protocols drove $90M in total specialty pharmacy savings, or $0.50PMPM savings on average.⁵

Learn more about how Accredo provides personalized care.

5. 2023 Evernorth Specialty Data

Doctor stands and talk with four other medical professionals in middle of hospital hallway

98%

patient satisfaction rate among patients with rare conditions⁵

5. 2021 Evernorth Specialty Data - Analytic & Reporting Consolidation
6. Accredo BoB data, 2022 and 2016-2022. Total includes manufacturer and charitable programs
7. Adherence Course Correct 6 month PDC analysis 2023

$7B

copay assistance coordinated for patients since 2016⁶

12%

increase in adherence following our proactive coaching⁷

Tools to support more informed benefit decisions

The evolving specialty landscape, including cell and gene therapies, has the potential to significantly impact your plan. Preparing for these therapies is critical to best support your members and to make informed decisions for your plan.

Download our guide that outlines the 5 steps you can take to prepare for a data-driven discussion on your gene therapy strategy.

View our guide

woman scientist eyeglasses blue glove on right hand faces right holds joystick button

Advocacy for access to lower cost, quality care

We develop strategies that inform meaningful, sustainable policy solutions on a wide range of health care issues. Our specialty solutions address the access and availability of biosimilars in the public eye, navigating state-level issues. We advocate for our clients and identify upcoming alternative solutions to remain compliant with new legislation, all the while retaining their options in how they want to manage their health care spend.